Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on Dec 20, 2022 5:40pm
167 Views
Post# 35183371

RE:RE:RE:RE:RE:7500000

RE:RE:RE:RE:RE:7500000
palinc2000 wrote:

It was reported as a Form T trade which is required for after/before hours trading on Naz


SABBOBCAT wrote:
Trogarzon wrote: A cross is not an OUT... also if it was really a seller.. you really needed a buyer... probably a tax move.  We'll know one day I guess...

Was it a cross? I cant see on my feed? 

 

My best guess is it was Morgan Stanley selling, given their shareholdings of right aroun 7.5 million as of 9/30) in a year-end window dressing exercise. If the buyer was a broker who is doing their client a favor by taking the position of their hands, then the selling pressure will abate somewhat a s the broker will be looking to make a profit on this trade and has more time to drip it out onto the market. So, we might see a small bounce but probably not a huge one as the broker would likely want to get at both quickly and profitably. If, on the other hand, the stock was sold to a scavenger type investor, we might see a more immediate and substantial bounce as the intense selling would stop as this investor would be playing it for a much larger bounce. Given the size of the transaction though, it does not appear that Morgan Stanley was the seller recently since they seemed to still hold the same position size they held on 9/30. So, the selling might continue if it is other sellers who have been pressuring the share price and not Morgan Stanley since they may have more selling to get done before the end of the year.

<< Previous
Bullboard Posts
Next >>